Gallagher Neil bought SNDX
February 7, 2024 · Form 4 insider transaction
Gallagher Neil bought 69,375 shares of Syndax Pharmaceuticals, Inc. at $22.28 per share, a transaction worth $1.55M. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
69,375
Price
$22.28
Total value
$1.55M
InsiderGallagher Neil
RoleOfficer, Director
SecurityStock Options (Right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 7, 2024
Filing dateFebruary 9, 2024
Shares owned after69,375
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
1/48th of the shares subject to the option shall vest monthly over a four-year period.